🐕

Canine Variable Domain Analyzer

VBASE3 Pan-Vertebrate Synthesis & Repertoire Platform — Canis lupus familiaris

🐕 Canis lupus familiaris: Veterinary mAbs & Lambda Dominance
Canine Antibody & Veterinary Biotherapeutic Workbench
Curated database of 29 Class I canine V-genes, benchmark caninized biotherapeutics (Lokivetmab, Bedinvetmab, Gilvetmab), and light chain lambda-dominance profiling.
29
Class I V-Genes
5
J-Segments
5
D-Elements
3
Benchmark mAbs
📥 Input Dog Antibody Sequence
DNA or Amino Acid
Load Landmark Preset:
📊 Analysis Results
🐕
Enter a Canine nucleotide or amino acid sequence, or click a landmark preset above to begin.
📚 Canine Class I Functional Repertoire Catalog
Sourced from Stratum 3 Master Catalog (Cys104 Anchored)
Gene ID Locus Chain Classification Mature V-Exon (to Cys104) RSS / Evidence Action
🔬 Benchmark Caninized Monoclonal Antibodies
Approved Veterinary Biotherapeutics
Clone / Therapeutic Clinical Target V / J Assignment Boundary Therapeutic Mechanism & Significance Action
🏛️ Caninization Engineering & Comparative Immunogenetics
Companion Animal Antibody Architecture

The Veterinary Monoclonal Antibody Revolution:

Companion animal therapeutics has undergone a rapid paradigm shift with the advent of "caninized" monoclonal antibodies. Rather than using small molecules with non-specific organ toxicity, veterinary medicine now utilizes high-affinity caninized antibodies engineered to match the natural canine immunoglobulin architecture.

Key Structural & Immunogenetic Hallmarks in VBASE3:

  • Inverted Light Chain Partitioning (~90% Lambda Dominance): Whereas humans exhibit ~60% Kappa and mice >95% Kappa, dogs display an inverted repertoire dominated by the Lambda light chain (~90% IGL vs. ~10% IGK). Therapeutic caninization campaigns must account for this structural preference when selecting light chain pairings.
  • Restricted Heavy Chain Families: The canine heavy chain repertoire is predominantly composed of Clan III-related IGHV genes that exhibit high homology to human IGHV3, greatly simplifying human-to-canine antibody conversion.
  • Strict IMGT Synthesis Boundaries: Canonical synthesis endpoints (TVSS for heavy, TVL for lambda, and VEIK/LEIK for kappa) ensure zero constant region bleed-through in recombinant veterinary production.
  • Repertoire-Confirmed Class I Functional Universe: All 29 canine V-genes in this analyzer represent confirmed functional segments with rearranged physiological evidence, trimmed strictly to Cys104.